| Rank | Holder | SharesFloat % | Change | Date reported |
|---|---|---|---|---|
| 1 | FMR Inc | 77.98M (13.83%) | 12.20M Increased by +15.65% | Mar 31, 26 |
| 2 | Morgan Stanley - Brokerage Accounts | 51.83M (9.19%) | -6.53M Decreased by -12.60% | Mar 31, 26 |
| 3 | BlackRock Inc | 44.25M (7.85%) | 3.08M Increased by +6.97% | Mar 31, 26 |
| 4 | Vanguard Group Inc | 42.06M (7.46%) | 3.25M Increased by +7.74% | Dec 31, 25 |
| 5 | Qvt Financial LP | 25.16M (4.46%) | -1.23M Decreased by -4.87% | Mar 31, 26 |
| 6 | UBS Group AG | 22.62M (4.01%) | 4.23M Increased by +18.69% | Mar 31, 26 |
| 7 | Vanguard Capital Management, LLC | 20.68M (3.67%) | 20.68M Increased by +100.00% | Mar 31, 26 |
| 8 | Vanguard Portfolio Management, LLC | 19.84M (3.52%) | 19.84M Increased by +100.00% | Mar 31, 26 |
| 9 | State Street Corporation | 17.15M (3.04%) | 3.43M Increased by +19.97% | Mar 31, 24 |
| 10 | SB INVESTMENT ADVISERS (UK) LTD | 16.41M (2.91%) | -23.90M Decreased by -145.62% | Dec 31, 25 |
| 11 | State Street Corp | 16.19M (2.87%) | -1.17M Decreased by -7.26% | Mar 31, 26 |
| 12 | Wellington Management Company LLP | 13.64M (2.42%) | -1.20M Decreased by -8.82% | Dec 31, 23 |
| 13 | Adage Capital Partners Gp LLC | 12.79M (2.27%) | 2.12M Increased by +16.54% | Mar 31, 26 |
| 14 | Patient Square Capital | 12.48M (2.21%) | 0.00 Increased by 0.00% | Jun 30, 25 |
| 15 | The Goldman Sachs Group Inc | 11.11M (1.97%) | 128.91K Increased by +1.16% | Mar 31, 26 |
| 16 | T. Rowe Price Investment Management,Inc. | 10.65M (1.89%) | 10.65M Increased by +100.00% | Sep 30, 23 |
| 17 | Geode Capital Management, LLC | 10.18M (1.81%) | 2.03M Increased by +19.93% | Mar 31, 26 |
| 18 | Farallon Capital Management, L.L.C. | 9.68M (1.72%) | 9.64M Increased by +99.62% | Mar 31, 26 |
| 19 | Two Seas Capital LP | 9.33M (1.65%) | -463.60K Decreased by -4.97% | Mar 31, 26 |
| 20 | Perceptive Advisors LLC | 8.29M (1.47%) | 300.00K Increased by +3.62% | Mar 31, 26 |
| Rank | Holder | SharesFloat % | Change | Date reported |
|---|---|---|---|---|
| 1 | Fidelity Growth Compy Commingled Pl S | 29.43M (5.22%) | 354.96K Increased by +1.21% | Apr 30, 26 |
| 2 | Fidelity Growth Company Fund | 22.34M (3.96%) | 277.40K Increased by +1.24% | Apr 30, 26 |
| 3 | Fidelity Growth Compy Commingled Pl O | 21.15M (3.75%) | 439.20K Increased by +2.08% | Aug 31, 24 |
| 4 | iShares Core S&P Mid-Cap ETF | 15.30M (2.71%) | 2.87K Increased by +0.02% | May 29, 26 |
| 5 | Vanguard Total Stock Mkt Idx Inv | 14.83M (2.63%) | 37.63K Increased by +0.25% | Apr 30, 26 |
| 6 | Vanguard US Total Market Shares ETF | 14.26M (2.53%) | 14.26M Increased by +100.00% | Sep 30, 24 |
| 7 | Fidelity® Growth Company | 10.84M (1.92%) | 288.60K Increased by +2.66% | Nov 30, 23 |
| 8 | Vanguard Small Cap Index | 10.72M (1.90%) | -20.55K Decreased by -0.19% | Apr 30, 26 |
| 9 | Vanguard Health Care Inv | 9.57M (1.70%) | 0.00 Increased by 0.00% | Dec 31, 23 |
| 10 | SPDR® S&P Biotech ETF | 7.21M (1.28%) | 16.07K Increased by +0.22% | Aug 31, 25 |
| 11 | Fidelity Growth Company K6 | 6.19M (1.10%) | 43.14K Increased by +0.70% | Apr 30, 26 |
| 12 | Invesco S&P MidCap Quality ETF | 6.02M (1.07%) | 0.00 Increased by 0.00% | May 30, 25 |
| 13 | Vanguard Small Cap Growth Index Inv | 6.01M (1.07%) | -3.18K Decreased by -0.05% | Apr 30, 26 |
| 14 | Fidelity Series Growth Company | 5.64M (1.00%) | -96.40K Decreased by -1.71% | Apr 30, 26 |
| 15 | Morgan Stanley Growth | 5.46M (0.97%) | -911.70K Decreased by -16.69% | Mar 31, 26 |
| 16 | Morgan Stanley Growth SMA | 5.46M (0.97%) | -911.70K Decreased by -16.69% | Mar 31, 26 |
| 17 | Morgan Stanley Inst Growth I | 5.46M (0.97%) | -911.70K Decreased by -16.69% | Mar 31, 26 |
| 18 | MS INVF US Advantage I | 5.31M (0.94%) | -375.50K Decreased by -7.08% | Mar 31, 26 |
| 19 | T. Rowe Price Mid-Cap Growth | 5.25M (0.93%) | 5.25M Increased by +100.00% | Sep 30, 23 |
| 20 | T. Rowe Price US Mid-Cap Growth Equity | 5.25M (0.93%) | 5.25M Increased by +100.00% | Sep 30, 23 |